Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Call Transcript

Chuck Kummeth : It will be this whole calendar year. They’re intending it for that. They’re intending it for health care. They’re intending it to be in hardware more than anything else. And we play big there. We’re about productivity and hardware. So we’ve got more platforms than ever. So we’re going to share in that as well. I mean just to put that into scope, it’s 1.7, if that’s the real number, that’s way bigger than our entire NIH budget. So it’s going to be good. It would be good for everybody.

Operator: We have reached the end of our question-and-answer session. I would now like to turn the floor back over to management for concluding comments.

Chuck Kummeth : All right. Well, thanks, everyone. We’ll see at the end of next quarter. I think we were as transparent as we can be. We’ve been doing this a long time together as a team, and we’ll always be transparent. Things still look really good here. We don’t see any change in our thesis. And anyway, I see the future is bright, we think. So we’ll talk to you soon. Thank you.

Operator: This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.